DAMA PERFETTA

  • ABOUT PRODUCT
  • INSTRUCTIONS
COMPOSITION AND DOSAGE FORM

Each film-coated tablet contains:

Grape Seed Extracе
Green Tea Extraсе
Lycopene
Soy Isoflavones
Collagen Peptide (Type 1)
Ascorbic acid (Vit. C)
Tocopherol acetate (Vit. E)
Biotin
Niacinamide
L-Glutathione
Zinc
Excipients: talc, microcrystalline cellulose, starch, dibasic calcium phosphate, magnesium stearate, colloidal silicon dioxide.

In a Package: 30 tablets.
Each tablet: 1150mg.

EFFECT OF THE SUPPLEMENT

The appearance of a person is, first of all, the beauty and youth of his/her skin, the shine of healthy hair, and, importantly, beautiful and well-groomed nails. The key task of cosmetologists is to preserve and extend female beauty. For these purposes, numerous cosmetics and various procedures are used everything that can protect the skin from the influence of external factors and withstand the most serious culprits of skin-aging – free radicals.

But no matter what means we use in the fight against age, the deficit of basic essential substances by external means is not compensated.

PROPERTIES OF ACTIVE INGREDIENTS

The composition of DAMA PERFETTA is rich and unique:

Grape seed extract, which promotes collagen synthesis, soothes, possesses antioxidant, capillary-strengthening, anti-inflammatory effect and restores skin youth and elasticity.

 Green tea extract is rich in antibacterial and antiseptic properties, in addition, it helps to normalize metabolic processes in the tissues, heal and soothe damaged skin, improve complexion, and also cleanse the skin and narrow pores. Caffeine, contained in green tea, helps to reduce puffiness, and also significantly improves skin nutrition and blood microcirculation, and the tannins in this invigorating drink make the skin more elastic.

 Lycopene for women is known for its cosmetic effect in protecting elastin and collagen from free radicals, strengthening and intertwining collagen fibers with an elastin chain, which slows down the aging process, slows down the elasticity of the skin, the appearance of aging spots and wrinkles.

Soy isoflavones are a natural source of the female hormone estrogen. This hormone is extremely important because it normalizes the hormonal background in the body of a woman, thereby preserving beauty and health. So, it is responsible for the appearance of the hair, the condition of the skin, greatly affects the course of the menstrual cycle and other cycles in the female body until old age. When the age of forty comes, a woman’s body produces significantly less estrogen.

Phytoestrogens of soybeans have a selective effect in the female body: they can have both estrogenic and anti-estrogenic activity, taking into account the amount of estrogen in the blood.

– The action of isoflavones is similar to the action of a woman’s own estrogen, which deprives the female body of possible side effects.

 Collagen is a protein that forms the basis of the connective fibers of the skin and provides it with strength, elasticity, and firmness. Accordingly, a lack of collagen in the body leads to sagging and wrinkles.

 Vitamin C has the following actions in its formulation:

Immune booster.

Rejuvenation. It has good antioxidant properties. There is a lifting effect without injections of beauty and plastic surgery.

Sun protection. Activation of the production of natural collagen leads to the protection of the epidermis from ultraviolet radiation. The self-regulation mode will be activated.

Protection against slagging. Helps to eliminate toxins from the body and dermis. Hence, puffiness and blockage are eliminated, blood circulation and metabolic processes are accelerated. Slags are removed with sweat and human waste without harm.

Tocopherol acetate (Vitamin E) has the following functions:

  • acts as a powerful antioxidant;
  • stimulates protein synthesis, promotes the formation of new cells, which is expressed by good tissue regeneration;
  • strengthens the immune system, protects cells from viruses and bacteria;
  • participates in the functions of internal secretion systems (ovaries, adrenal glands, thyroid gland, pituitary gland), stimulates the production of hormones.

Biotin contains B vitamins, which contribute to the absorption and processing of fats, proteins and carbohydrates. Biotin is also prescribed for the treatment and growth of hair in cases where there is an appearance of gray hair, brittleness, increased oily hair, and their dryness.

A biotin deficiency can lead to poor nutrition of the hair follicle with beneficial substances.

 L-Glutathione assists to get rid of free radicals, which can greatly harm a human body. Free radicals are highly active compounds that destroy cells. Another important fact that menopause leads to a decrease in glutathione levels. For many women, this is comparable to tragedy, since at this time the aging process becomes most obvious.

Adequate glutathione in the body can slow down the aging process. Glutathione is a knight which fights for the youth and beauty of the skin.

Glutathione is a natural way to lighten skin.

Studies have shown that increasing glutathione levels makes the skin more radiant and lighter. This is due to the fact that glutathione stimulates the production of various types of melanin.

Zinc is absolutely necessary for the formation of collagenase, an enzyme that promotes the rejection of dead and old cells of the upper layer of the epidermis and accelerates the process of skin renewal.

SIDE EFFECTS

Side effects are very rare. If serious side effects occur, intake of the supplement should be discontinued immediately and it is advised to consult a doctor.

INTERACTION WITH OTHER MEDICATIONS

There are no data on the interaction with any other medications.

INDICATIONS
  • Compensation for deficiency of vitamins and other necessary elements;
  • Elimination of age-related collagen deficiency, slowing down the aging process;
  • Improving the appearance of skin, hair, and nails;
  • Reducing the manifestations of cellulite;
  • Weight loss.
CONTRAINDICATIONS

Pregnancy, childhood, hypersensitivity to the supplement.

DOSAGE AND ADMINISTRATION

The duration of treatment and the dose is determined by a physician for each patient individually.

ADULTS

1 tablet 2 times a day during a meal.

The supplement is recommended to be taken at the same time while eating. Tablets should be swallowed wholly without chewing with a small amount of liquid.

The duration of treatment is between 3-6 months.

If necessary, it is possible to increase the duration of the course of treatment or its repetition.

OVERDOSE

No cases of adverse events resulting from an overdose of the supplement have been reported.

STORAGE CONDITIONS AND SHELF LIFE

The supplement should be stored in a cool, dry, dark place and out of the reach of children at a temperature of + 2°C + 25°C. Protect from direct sunlight and moisture.
Shelf life: 24 months.

The information presented on the site should not be used for self-diagnosis and treatment and can not serve as a substitute for a doctor's internal consultation.

3

MIGRENAZ – L

  • ABOUT PRODUCT
  • INSTRUCTIONS
COMPOSITION AND PACKING

Syrup of herbal extracts, brown viscous liquid with individual odor (may have light sediment and clouding) in the original vials of 100 ml with a protective seal – (1) cardboard packs with protective branded holographic label; (2) Spoon – dispenser; (3) instruction for use.

Composition:   

Common Valerian Extract (Valeriána officinális)
Brandy Mint Extract (Méntha piperíta)
Ginkgo Biloba Extract (Gīnkgo Biloba)
May Lily Extract (Convallária majális)
Field Caraway Extract (Fructus Carvi)
Blood-Red Hawthorn Extract (Crataégus sanguínea)

EFFECT OF THE MEDICINE
  • Improves cerebral blood circulation and brain oxygen supply;
  • Affects the metabolism of the cells, blood rheology and improves peripheral circulation and microcirculation;
  • Expressed anti-edema effect on the level of the brain and in peripheral tissues;
  • It has an anti-stress effect on the normalization of post-stress behavior, somatic-vegetative violations, restoration of the sleep-wake cycles, broken processes of learning and memory, and reducing degenerative
    morphological changes in different brain structures.
SIDE EFFECTS

There may be rarely allergic hypersensitivity to separate ingredients of the preparation.
Use of the medicine should be discontinued when hypersensitivity reactions occur.
The usage of the medicine must be informed to the doctor before the surgery.

SPECIAL INSTRUCTIONS

Before use, carefully shake the vial.
Keep the vial in a cool place after opening it. Do not heat and do not freeze.

INTERACTION WITH OTHER MEDICATION

When prescribing with other medication adverse effects were not revealed.

INDICATIONS

Migrenaz – L is used in the treatment and prevention of the following:

  • Acute and chronic cerebral circulatory disorders;
  • Mild traumatic brain injury (Mild concussion);
  • Vegetative dystonia syndrome;
  • Mild cognitive impairment of atherosclerotic nature;
  • Disorders of memory and mental activity;
  • Vertigo, tinnitus, feelings of fear;
  • Violation of peripheral blood circulation and microcirculation (including arteriopathy of the lower limbs and pediatric orthopedics), Raynaud’s syndrome.
CONTRAINDICATIONS

Individual intolerance to certain ingredients of the medicine.

DOSAGE

The duration of treatment and the dose are determined by the attending physician for each patient individually.

CHILDREN FROM 1 TO 3 YEARS OLD

CHILDREN FROM 4 TO 12 YEARS OLD

ADULTS AND CHILDREN FROM 12 YEARS OLD AND ABOVE

1.0-2.5 ml 2-3 times a day

3.0-5.0 ml 2-3 times a day

5.0-7.5 ml 2-3 times a day

For peroral use, 5-10 minutes before the meal. The course of treatment is at least 3 months (especially in elderly patients).
Courses can be repeated after consultation with the doctor.

OVERDOSE

The cases of overdose were not reported.

STORAGE CONDITIONS AND EXPIRATION DATE

The medicine should be stored out of reach of children, protected from light, at a temperature from + 2° C to + 25°C.

Expiration date: 24 months

The information presented on the site should not be used for self-diagnosis and treatment and can not serve as a substitute for a doctor's internal consultation.

3

PANKRIAZOL

  • ABOUT PRODUCT
  • INSTRUCTIONS
COMPOSITION AND PACKAGING

Round tablets of herbs, with individual odor, biconvex, light – brown, speckled tablets. 60 pieces 0.5 g each. Polyethylene vials with a protective seal or packed in blisters. (1) – cardboard pack with protective holographic label, (2) – instruction for use.

Composition:

Myrtleflag (Acorus calamus L.)
Flint Corn (Zea mays L.)
Flax Seeds (lini seed)
Chamomile (Matricaria chamomilla L)
St. John’s-worts (Hypericum perforatum L.).
Marigold Officinalis (Calendula officinalis L.)
Common Wormwood (Artemisia absinthium L)

EFFECT OF THE MEDICINE

The medicine normalizes secretory and motor functions of the choledochopancreatic system and has anti-inflammatory action.

SIDE EFFECTS

There may be rare allergic reactions in the case of individual sensitivity to separate components of the medicine.
Use of the medicine should be discontinued when hypersensitivity reactions occur.

INTERACTION WITH OTHER MEDICATION

When prescribing with other medication adverse effects were not revealed.

INDICATIONS

The medicine is prescribed in the following cases:

  • Lack of the secretory function of the pancreas (chronic pancreatitis – inflammation of the pancreas, cystic fibrosis – an inherited disease characterized by obstruction of the output ducts of the pancreas, respiratory
    tract and intestinal glands by viscous secretion, etc.);
  • Chronic inflammatory and degenerative diseases of the stomach, intestines, liver, gall bladder;
  • Status after resection or irradiation of these organs, accompanied by maldigestion, flatulence (gas accumulation in the gut), diarrhea (flux) – in combination therapy;
  • State after pancreatectomy (removal of the pancreas);
  • Obstruction of the pancreas ducts or biliary tract;
  • To improve digestion in patients with the normal function of the gastrointestinal tract in the case of noncompliance to diet, as well as chewing dysfunction, forced prolonged immobilization, sedentary lifestyle;
  • Preparation for X-ray and ultrasound examination of the abdominal cavity.
  • Cholangitis.
CONTRAINDICATIONS

Acute pancreatitis, chronic pancreatitis in the acute phase.
Individual intolerance to certain ingredients of the medicine.

DOSAGE

The duration of treatment and the dose are determined by the attending physician for each patient individually.

ADOLESCENTS AND CHILDREN 17 YEARS OLD AND BELOW

ADULTS

1 tablet 3 times a day

2 tablets 3 times a day

Tablets are taken with meals, swallowed as a whole with plenty of non-alkaline liquid (water, fruit juices).

Duration of treatment may vary from a few days (in case of maldigestion due to deviation from the diet) to several months or even years (permanent replacement therapy if necessary).

If necessary the treatment course can be repeated.

OVERDOSE

The cases of the medicine overdose were not reported.

STORAGE CONDITIONS AND EXPIRATION DATE

The medicine should be stored out of reach of children, protected from light, at a temperature from + 2° C to + 25°C.

Expiration date: 2 years

The information presented on the site should not be used for self-diagnosis and treatment and can not serve as a substitute for a doctor's internal consultation.

3

FEMALIFE

  • ABOUT PRODUCT
  • INSTRUCTIONS
COMPOSITION AND PACKING

Round tablets of herbs, with individual odor, biconvex, light – brown, speckled tablets. 60 pieces 0.5 g each. Polyethylene vials with a protective seal or packed in blisters. (1) – cardboard pack with protective holographic label, (2) – instruction for use.

Composition:

Lemon balm (Melissa officinalis L.)
The common fennel (Fructus Foeniculi)
Breckland thyme (Herba Serpylli)
Anise fruits (Fructus Pimpinella anisum L.)

EFFECT OF THE MEDICINE
  • one of the few natural products developed to preserve and maintain breastfeeding with insufficient lactation.
  • contributes to the extension of the period of natural breastfeeding, leads to an early recovery of the organism of the breastfeeding woman in the postpartum period and supports it during feeding.
  • The basis of FEMALIFE is herbs and their seeds, which have long been used in folk medicine with a lack of milk from breastfeeding women.
SIDE EFFECTS

Usually, side effects do not occur, in most cases, the medication is well tolerated.

There may be allergic reactions (itching, rash), as well as nausea, headache, a feeling of bitterness in the mouth. Use of the medicine should be discontinued when hypersensitivity reactions occur and consult a doctor.

SPECIAL INSTRUCTIONS

After opening the vile, store in a cool place.

INTERACTION WITH OTHER MEDICATIONS

When prescribing with other medication adverse effects were not revealed.

INDICATIONS
  • Increases lactation and replenishes the lack of vitamins and minerals in the body of a woman during breastfeeding;
  • Possesses antibacterial and pronounced antioxidant effect;
  • Helps relieve stress and fatigue;
  • Strengthens the immune system;
CONTRAINDICATIONS

Hypersensitivity to some components of the medicine.

DOSAGE

The duration of treatment and the dose are determined by the attending physician for each patient individually.

INSIDE

2 tablets 2-3 times a day, half an hour before meals.

Duration is not limited (usually for the entire period of breastfeeding the baby).

OVERDOSE

The cases of overdose were not reported.

STORAGE CONDITIONS AND EXPIRATION DATE

The medicine should be stored out of reach of children, protected from light, at a temperature from + 2° C to + 25°C.

Expiration date: 24 months

The information presented on the site should not be used for self-diagnosis and treatment and can not serve as a substitute for a doctor's internal consultation.

3

SLABIZIN

  • ABOUT PRODUCT
  • INSTRUCTIONS
COMPOSITION AND PACKING

Syrup of herbal extracts, brown viscous liquid with individual odor (may have light sediment and clouding) in the original vials of 150 ml with a protective seal – (1) cardboard packs with a protective branded holographic label; (2) spoon – dispenser; (3) instruction for use.

Composition:

Aloe Extract (Aloe arborescens Mill.)
Rhubarb Extract (Rheum L.)
Plantains Extract (Plantago L.)
Egyptian senna (Senna Alexandrina)

EFFECT OF THE MEDICINE
  • Slabizin – anthraglycoside containing a preparation of plant origin, possesses a laxative effect coming in 8-10 hours.
  • The laxative effect is due to the effect on the receptors of the large intestine, which increases peristalsis.
  • It transforms in the digestive tract, begins to irritate the walls of the large intestine, stimulates its work, but it does not cause spasms.
  • The medicine is designed to purify the intestines and restore healthy microflora.
  • Promotes the reproduction of healthy and necessary for normal functioning of microflora: enterococci, bifidobacteria, lactobacilli, etc.
SPECIAL INSTRUCTIONS

Shake the vial before using it.
It is not recommended to use medicine for more than 2 weeks.
After taking the medicine, urine can acquire a yellow-brown or red-lilac color.

With caution: it is prescribed for liver and/or kidney diseases, as well as during pregnancy and lactation, in conditions after cavitary operations, as well as children’s age (up to 6 years) based on the dosing regimen.

SIDE EFFECTS

The laxative effect of the medicine may be accompanied by colic pain in the abdomen and flatulence.

With prolonged use, particularly at high doses, there could be possible violations of water-electrolyte metabolism, albuminuria, hematuria, melanin deposition in the intestinal mucosa, nausea, vomiting, diarrhea, urinary discoloration, skin rash, seizures, vascular collapse, fatigue,
and confusion.

INTERACTION WITH OTHER MEDICATIONS

With prolonged use of Slabizin in high doses, it is possible to increase the action of cardiac glycosides and influence the effect of antiarrhythmic medicines in connection with the possibility of developing hypokalemia.

With simultaneous use with thiazide diuretics, glucocorticoids, licorice root preparations, the risk of hypokalemia increases.

INDICATIONS

The medicine Slabizin is prescribed for:

  • Crohn’s disease;
  • chronic and acute constipation (regulation of the physiological rhythm of emptying the large intestine);
  • constipation caused by hypotension and sluggish peristalsis of the large intestine;
  • chronic spasmodic colitis;
  • regulation of stool with hemorrhoids, proctitis, anal fissures;
  • softening of the stool for medical purposes (with hemorrhoids, conditions after surgery on the large intestine and in the anal area).
    CONTRAINDICATIONS
  • chronic intestinal obstruction;
  • acute stomach syndrome;
  • appendicitis;
  • intestinal obstruction;
  • abdominal pain of unknown origin;
  • gastrointestinal and uterine bleeding;
  • women during critical days and in the period of gestation;
  • violations of water-electrolyte exchange.
  • hypersensitivity to one or more of the components of the medicine.
DOSAGE

The duration of treatment and the dose are determined by the attending physician for each patient individually.
Slabizin is taken orally, usually 1 time per day in the evening before bedtime:

ADULTS AND CHILDREN OVER 12 YEARS OF AGE

CHILDREN BETWEEN 6-12 YEARS OF AGE

10-15 ml for each intake. In the absence of the effect, the dose can be increased to 20-25 ml

5-10ml. for each intake and, if necessary, the dose can be increased up to 15ml. for each intake

In the process of selection, the same dose should be taken for several days and gradually increased by 5 ml. syrup. If defecation does not occur after reaching the maximum dose within 3 days, one needs to see a doctor.

OVERDOSE

The cases of overdose were not reported.

STORAGE CONDITIONS AND EXPIRATION DATE

The medicine should be stored out of reach of children, protected from light, at a temperature from + 2° C to + 25°C.

Expiration date: 2 years

The information presented on the site should not be used for self-diagnosis and treatment and can not serve as a substitute for a doctor's internal consultation.

3

DOLGOJITEL №5

  • ABOUT PRODUCT
  • INSTRUCTIONS

DOLGOJITEL №5 – FOR PEOPLE WITH PHYSICAL DISABILITIES

COMPOSITION AND DOSAGE FORM

DOLGOJITEL № 5, 0.25 gr. in each capsules, 60 pcs of capsules packaged in original bottles with a protective seal. (1) – cardboard pack with protective holographic label, (2) – instruction for use.

Composition:

Dihydroquercetin (Taxifolin) 92% 50 mg.
Arabinogalactan 140 mg.
Starch 60 mg.
EFFECT OF THE MEDICINE
  • The preparation is intended for people with physical disabilities and for those who have to lead a sedentary lifestyle.
  • Dihydroquercetin and arabinogalactan help to ensure the normal functioning of the body, deprived of the natural possibilities.
  • This complex increases vitality, thereby improving the quality of life and increasing its endurance.
SIDE EFFECTS

Usually, there are no side effects; in the majority of cases, the drug is well tolerated.
Use of the drug should be discontinued when hypersensitivity reactions occur.

CONTRAINDICATIONS

Hypersensitivity to one or more components of the drug.

INTERACTION WITH OTHER MEDICATION

When prescribing with other medication adverse effects were not revealed.

INDICATION

As a means of prevention:

During immunity disorders:

  • recommended as a tonic to enhance the body’s defenses;
  • increases the body’s resistance to infectious diseases and the harmful effects of the environment.

During exacerbation and complication of inflammatory diseases:

  • reduces the severity of inflammatory processes;
  • staves off exacerbations and recurrence of chronic inflammatory diseases.

In cardiovascular diseases:

  • contributes to the normalization of blood pressure;
  • improves blood microcirculation and cerebral circulation;
  • reduces the effects of hypoxia and ischemia.
Dosage and Administration

The duration of treatment and the dose are determined by a physician for each patient individually.

PATIENTS BETWEEN 3 AND 9 YEARS OF AGE

PATIENTS BETWEEN 9 AND 18 YEARS OF AGE

PATIENTS ABOVE 19 YEARS OF AGE

1 capsule 1 time a day with meals.

1 capsule 2 times a day with meals.

1 capsule 3 times a day with meals.

Duration of admission

4-8 weeks.

Repeated course after 2 weeks.
Consult with your doctor before use.

STORAGE CONDITIONS AND EXPIRATION DATE

The medicine should be stored out of reach of children, protected from light at a temperature from + 2° C to + 25°C.
Expiration date: 24 months

Not considered as a pharmaceutical medicine.

The information presented on the site should not be used for self-diagnosis and treatment and can not serve as a substitute for a doctor's internal consultation.

3

DOLGOJITEL №4

  • ABOUT PRODUCT
  • INSTRUCTIONS

DOLGOJITEL №4 – FOR GASTROINTESTINAL TRACT / HEPATOPROTECTOR

COMPOSITION AND DOSAGE FORM

DOLGOJITEL № 4, 0.25 gr. in each capsule, 60 pcs of capsules packaged in original bottles with a protective seal. (1) – cardboard pack with protective holographic label, (2) – instruction for use.

Composition:

Dihydroquercetin (Taxifolin) 95% 25 mg.
Arabinogalactan 120 mg.
Starch 105 mg.
EFFECT OF THE MEDICINE
  • The preparation with a high content of arabinogalactan is intended for people with gastrointestinal diseases.
  • Arabinogalactan stimulates intestinal peristalsis and helps restore normal microflora, thereby improving the work of the gastrointestinal tract.
  • Dihydroquercetin (DHQ), due to its antibacterial properties, does away with Helicobacter.
  • Moreover, this medication improves the functional state of liver cells, supports its anti-toxic function and is effective for people suffering from constipation.
SIDE EFFECTS

Usually, there are no side effects; in the majority of cases, the drug is well tolerated.
Use of the drug should be discontinued when hypersensitivity reactions occur.

CONTRAINDICATIONS

Hypersensitivity to one or more components of the drug.

INTERACTION WITH OTHER MEDICATION

When prescribing with other medication adverse effects were not revealed.

INDICATION

As part of complex therapy for diseases of the gastrointestinal tract and liver:

In dysbacteriosis:

  • improves nutrition and growth of bifidobacteria and lactobacilli;
  • promotes splitting, absorption and assimilation of nutrients in the gastrointestinal tract.

With gastric ulcer and duodenum:

  • as part of traditional treatment, it leads to a more rapid and effective reduction of pain, dyspeptic disorders (nausea, vomiting, heartburn, appetite disturbances, feeling of an unpleasant taste in the mouth, flatulence);
  • tends to have a protective effect on the mucous membrane;
  • contributes to the healing of gastric and duodenal ulcers.

During gastritis:

  • improves regeneration of the gastric mucosa, reduces the severity of inflammatory processes.

In the course of liver dysfunction when it is impaired:

  • promotes the regeneration of liver cells and stimulates their biosynthetic function;
  • reduces the effect of toxins on the liver cells;
  • eliminates the symptoms of biliary dyskinesia.
Dosage and Administration

The duration of treatment and the dose are determined by a physician for each patient individually.

PATIENTS BETWEEN 3 AND 9 YEARS OF AGE

PATIENTS BETWEEN 9 AND 18 YEARS OF AGE

PATIENTS ABOVE 19 YEARS OF AGE

1 capsule 1 time a day with meals.

1 capsule 2 times a day with meals.

1 capsule 3 times a day with meals.

Duration of admission

4-8 weeks.

Repeated course after 2 weeks.
Consult with your doctor before use.

STORAGE CONDITIONS AND EXPIRATION DATE

The medicine should be stored out of reach of children, protected from light at a temperature from + 2° C to + 25°C.
Expiration date: 24 months

Not considered as a pharmaceutical medicine.

The information presented on the site should not be used for self-diagnosis and treatment and can not serve as a substitute for a doctor's internal consultation.

3

DOLGOJITEL №3

  • ABOUT PRODUCT
  • INSTRUCTIONS

DOLGOJITEL № 3 – FOR CARDIOVASCULAR SYSTEM

COMPOSITION AND DOSAGE FORM

DOLGOJITEL №3, 0.25 gr. in each capsule, 60 pcs of capsules packaged in original bottles with a protective seal. (1) – cardboard pack with a protective holographic label; (2) – instruction for use;

Composition:

Dihydroquercetin (Taxifolin) 95% 50 mg.
Acidum ascorbinicum 125 mg.
Starch 75 mg.
EFFECT OF THE MEDICINE
  • strengthens the walls of blood vessels and capillaries, increasing their strength and elasticity;
  • increases blood flow velocity, while improving microcirculation and the tone of the capillary bed;
  • prevents the formation of internal blood clots, which is the cause of many cardiovascular diseases;
  • improves the rheological properties of blood, its viscosity, and clotting, weakens the aggregation of red blood cells, improves their deformability in diseases involving increased blood viscosity syndrome (cerebral ischemia of the brain and heart, hypertension, diabetes);
  • evinces membrane stabilizing activity, reducing the severity of the inflammatory process;
  • reduces the level of cholesterol, lipids in the liver and serum;
  • inhibits age-related changes in blood vessels, while slowing the progression of vascular diseases;
  • reduces blood clots and the risk of progression of diabetic vascular complications, positively affecting the permeability of blood vessels.
SIDE EFFECTS

Usually, there are no side effects; in the majority of cases, the drug is well tolerated.
Use of the drug should be discontinued when hypersensitivity reactions occur.

CONTRAINDICATIONS

Hypersensitivity to one or more components of the drug.

INTERACTION WITH OTHER MEDICATION

When prescribing with other medication adverse effects were not revealed.

INDICATIONS

In the complex therapy of cardiovascular diseases:

In atherosclerosis:

  • During the course of treatment with Dolgojitel №3, the total cholesterol concentration decreases, as well as the coefficient of atherogenic serum decreases, and triglyceride levels in the blood reduces. This helps to reduce the clinical presentations of atherosclerosis.

In ischemic heart disease, heart failure, heart rhythm disorders:

  • Dolgojitel №3 helps to improve the rheological properties of blood, improves the condition of the membranes, increases their deformability, improves hemodynamic parameters.

During arterial hypertension of I and II degree.  

  • Under the influence of Dolgojitel №3, blood pressure normalizes, the amplitude of its daily fluctuations decreases, vascular tone ameliorates, cerebral circulation improves. As a result, it decreases headache and dizziness.

For prevention and in the period of rehabilitation after a stroke and heart attack.

  • Dolgojitel №3 restores microcirculation, helps to improve venous outflow, reduces hypoxia, renders a positive effect on metabolic processes in cells. Moreover, it helps to prevent the recurrence of the disease.
Dosage and Administration

The duration of treatment and the dose are determined by a physician for each patient individually.

PATIENTS BETWEEN 9 AND 18 YEARS OF AGE

PATIENTS ABOVE 19 YEARS OF AGE

1 capsule 2 times a day with meals.

1 capsule 3 times a day with meals.

Duration of admission

4-8 weeks.

Repeated course after 2 weeks.
Consult with your doctor before use.

STORAGE CONDITIONS AND EXPIRATION DATE

The medicine should be stored out of reach of children, protected from light at a temperature from + 2° C to + 25°C.
Expiration date: 24 months

Not considered as a pharmaceutical medicine.

The information presented on the site should not be used for self-diagnosis and treatment and can not serve as a substitute for a doctor's internal consultation.

3

DOLGOJITEL №2

  • ABOUT PRODUCT
  • INSTRUCTIONS

DOLGOJITEL №2 – RESTORATIVE

COMPOSITION AND DOSAGE FORM

DOLGOJITEL № 2, 0.25 gr. in each capsule, 60 pcs of capsules packaged in original bottles with a protective seal. (1) – cardboard pack with protective holographic label, (2) – instruction for use.

Composition:

Dihydroquercetin (Taxifolin) 92% 45 mg.
Acidum ascorbinicum 25 mg.
Starch 180 mg.
INDICATIONS
  • Restorative agent, indispensable for any person in a modern rhythm of life;
  • General languor, a decrease in physical and intellectual performance, absent-mindedness, depression – these are signs of inadequate tissue supply with nutrients and oxygen as well as an insufficient rate of excretion of degraded products.
  • Dihydroquercetin and its derivatives, through strengthening tissues of blood vessels, contribute to the restoration of their transport function and the disposal of “manager’s syndrome”;
  • Taxifolin is an excellent preventive agent for slowing down the aging process in the body.
SIDE EFFECTS

Usually, there are no side effects; in the majority of cases, the drug is well tolerated.
Use of the drug should be discontinued when hypersensitivity reactions occur.

CONTRAINDICATIONS

Hypersensitivity to one or more components of the drug.

INTERACTION WITH OTHER MEDICATION

When prescribing with other medication adverse effects were not revealed.

INDICATION

In case of immunity disorders:

  • It is recommended as a tonic to strengthen the body’s defenses, resistance to infectious diseases and the harmful effects of the environment.

In exacerbations and complications of inflammatory diseases:

  • resistance improves, the severity of the inflammatory process reduces, the exacerbation and recurrence of chronic inflammatory diseases stave off.

In the course of liver dysfunction when it is impaired:

  • the functional condition of the liver cells improves, and its antitoxic function will be maintained.

In varicose veins, phlebothrombosis, with post-thrombophlebitic syndrome:

  • strengthens the venous walls, improves venous blood flow, prevents thrombosis and reduces edema.

In the complications of diabetes:

  • improves microcirculation, strengthens the capillary bed, reduces insulin resistance, and improves the quality of life.
Dosage and Administration

The duration of treatment and the dose are determined by a physician for each patient individually.

PATIENTS BETWEEN 3 AND 9 YEARS OF AGE

PATIENTS BETWEEN 9 AND 18 YEARS OF AGE

PATIENTS ABOVE 19 YEARS OF AGE

1 capsule 1 time a day with meals.

1 capsule 2 times a day with meals.

1 capsule 3 times a day with meals.

Duration of admission

4-8 weeks.

Repeated course after 2 weeks.
Consult with your doctor before use.

STORAGE CONDITIONS AND EXPIRATION DATE

The medicine should be stored out of reach of children, protected from light at a temperature from + 2° C to + 25°C.
Expiration date: 24 months

Not considered as a pharmaceutical medicine.

The information presented on the site should not be used for self-diagnosis and treatment and can not serve as a substitute for a doctor's internal consultation.

3

DOLGOJITEL №1

  • ABOUT PRODUCT
  • INSTRUCTIONS

DOLGOJITEL № 1 – FOR ATHLETES

COMPOSITION AND DOSAGE FORM

DOLGOJITEL №1, 0.25 gr. in each capsule, 60 pcs of capsules packaged in original bottles with a protective seal. (1) – cardboard pack with a protective holographic label; (2) – instruction for use;

Composition:

Dihydroquercetin (Taxifolin) 95% 40 mg.
Arabinogalactan 80 mg.
Acidum ascorbinicum 25 mg.
Starch 105 mg.
INDICATIONS
  • for athletes and people whose life is associated with great physical and emotional stress;
  • increases endurance and stamina;
  • improves efficiency;
  • helps to concentrate as much as possible on achieving a result.
SIDE EFFECTS

Usually, there are no side effects; in the majority of cases, the drug is well tolerated.
Use of the drug should be discontinued when hypersensitivity reactions occur.

CONTRAINDICATIONS

Hypersensitivity to one or more components of the agent.

INTERACTION WITH OTHER MEDICATION

When prescribing with other medication adverse effects were not revealed.

Dosage and Administration

The duration of treatment and the dose are determined by a physician for each patient individually.

PATIENTS BETWEEN 9 AND 18 YEARS OF AGE

PATIENTS ABOVE 19 YEARS OF AGE

1 capsule 2 times a day with meals.

1 capsule 3 times a day with meals.

Duration of admission

4-8 weeks.

Repeated course after 2 weeks.
Consult with your doctor before use.

STORAGE CONDITIONS AND EXPIRATION DATE

The medicine should be stored out of reach of children, protected from light at a temperature from + 2° C to + 25°C.
Expiration date: 24 months

Not considered as a pharmaceutical medicine.

The information presented on the site should not be used for self-diagnosis and treatment and can not serve as a substitute for a doctor's internal consultation.

3